Product > Medical Equipment

Low-Level Laser Therapy Device(LLLT)

Low-Level Laser Therapy (LLLT) is a broad term encompassing low-power laser treatments. LLLT includes Photobiomodulation (PBM) and Intravenous Laser Irradiation of Blood (ILIB). In the market, this treatment is also known as "Biochemical Laser," "Photobiomodulation," "Laser Blood Purification," "Venous Laser," "Low-Energy Vascular Laser Photon Rehabilitation Therapy," etc.

Treatment principle: This method uses laser light of a specific wavelength to irradiate the blood, enhancing the oxygen-carrying capacity of red blood cells. The light energy is converted into bioenergy, similar to giving the blood a sunbath, thereby increasing cellular energy to promote the body's repair process and reduce pain or inflammation.

This technology was initially developed by Russian scientists in the 1980s, primarily for the treatment of cardiovascular diseases, and has since been widely applied in the fields of neurology/rehabilitation medicine, cosmetic medicine, and preventive medicine.

• Improves blood flow
• Boosts immunity
• Antioxidant effects
• Promotes cell activity

The non-invasive, patented innovative design allows circulating blood to be fully exposed to light without any contamination.

Effects of blood passing through the extracorporeal circulation system:

• Dialysis can lead to red blood cell destruction, and the kidneys may not be able to produce enough red blood cells.


• Some dialysis membranes may induce inflammatory responses, affecting immune system function.


• Anticoagulants used during dialysis (such as heparin) may affect platelet function, increasing the risk of bleeding. Contact between the dialysis membrane and blood may also lead to platelet activation, increasing the risk of thrombosis.


• Dialysis patients have a higher risk of cardiovascular disease, potentially leading to heart failure or arteriosclerosis.